Life Science Investing Quantum-Si Highlights Significant Development Advancements for Proteus and Industry Leading Technology Pipeline at Investor & Analyst Day
Life Science Investing Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
Life Science Investing Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Life Science Investing Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
Life Science Investing Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
Life Science Investing Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Locksley Strengthens U.S. Defense Supply Chain Strategy with Appointment of Lockhead Martin Materials Leader to Advisory Board
